GPT-Rosalind for skin microbiome analysis — L'Oréal is deploying a specialized AI model called GPT-Rosalind, developed by OpenAI for life sciences, to analyze the skin microbiome. The initial focus is on La Roche-Posay, aiming to identify beneficial bacteria and accelerate the development of next-generation, naturally-derived skincare products .
CreAItech for content creation — OpenAI's latest models will power L'Oréal's CreAItech marketing production system, accelerating the generation of beauty content at scale . Over 73,000 L'Oréal employees have already been trained in generative AI
.
3CE (3 Concept Eyes) — Already part of L'Oréal's portfolio since 2018, 3CE continues to scale globally from Seoul with a focused strategy on core categories like lips, blush, and eyeshadow . The brand now operates in nine countries
.
Dr.G — L'Oréal completed its acquisition of Dr.G (via Gowoonsesang Cosmetics) from Swiss retail group Migros in 2024–2025 . In April 2026, L'Oréal installed a new general manager to lead Dr.G's global expansion, signaling the brand is now fully integrated into L'Oréal's portfolio
. The acquisition includes discontinuing secondary brands Vividraw and Heals to focus exclusively on Dr.G
.
These additions give L'Oréal a two-pronged K-beauty strategy — 3CE in color cosmetics and Dr.G in dermatological skincare — as the group positions Korea as a key innovation hub and global growth engine .
The collaboration marks one of the deepest integrations of a major AI platform into a beauty company's operations. By embedding product discovery and virtual try-ons directly into ChatGPT, L'Oréal is betting that conversational AI will become a primary shopping interface. The use of GPT-Rosalind for microbiome research also signals that AI is moving beyond marketing into the core science of skincare formulation.
Comments
0 comments